Restasis (cyclosporine) is a brand-name prescription drug that’s used to treat chronic dry eye. Learn about side effects, warnings, dosage, and more.

Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA ® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...

This was a phase 4, single-arm, multicenter study during which patients with uncontrolled dry eye who had been on Restasis [cyclosporine 0.05%] for greater than or equal to 3 months were then ...

Learn about uses, side effects, price, and more for Restasis (cyclosporine). It’s a prescription eye drop that treats chronic dry eye in adults and some children.

When we prescribe Restasis (cyclosporine ophthalmic emulsion 0.05%, AbbVie), we know exactly what we are getting. ... Sun Pharmaceutical) and Vevye (cyclosporine ophthalmic solution 0.1%, ...

Xiidra comes as a liquid solution, while Restasis comes as an emulsion (liquid mixture of oil and water). ... Cequa (cyclosporine ophthalmic solution) 0.09%, for topical ophthalmic use. (2022) ...

Richard Adler, MD, FACS, discusses the Switch trial which compared OTX-101 (cyclosporine ophthalmic solution 0.09%) vs cyclosporine ophthalmic emulsion 0.05% (Restasis) in patients with dry eye ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and includes its subsidiaries and/or associate companies) today announced the ...

Presentation at the American Academy of Optometry (AAOPT) 2023 showed significant improvements with CEQUA® for topical ophthalmic use in both corneal fluorescein staining (CFS) and symptom ...